Double Trouble: EPCAM Exon 9 Deletion in Lynch Syndrome Leading to Dual Primary Tumors
Areti Kalfoutzou1, Cleopatra Rapti1, Zannis Almpanis2
1Department of Medical Oncology, 251 Air Force General Hospital, Athens, GRC.
Abstract:
Lynch syndrome (LS) is one of the most widely recognized cancer susceptibility syndromes and is caused by germline mutations of the mismatch repair (MMR) genes MLH1, MSH2, PMS2, and MSH6. One of the less commonly known mechanisms is the deletion of the 3' end of the Epithelial Cell Adhesion Molecule (EPCAM) gene, which is closely situated to the MSH2 gene promoter. Such deletion causes hypermethylation of the MSH2 gene promoter and leads to its inactivation. This case reports a young adult diagnosed with two metachronous primary tumors due to a germline EPCAM exon 9 deletion and subsequent MSH2 gene inactivation, shedding light on one of the most underrecognised pathways of microsatellite instability.
More Related Videos
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
07:44Non-Invasive Ultrasound Assessment of Endometrial Cancer Progression in Pax8-Directed Deletion of the Tumor Suppressors Arid1a and Pten in Mice
Published on: February 17, 2023
